Med Gen Announces Release of FABULUST(R)
Monday October 15, 8:00 am ET
BOCA RATON, Fla.--(BUSINESS WIRE)--Med Gen Inc. (OTCBB:MGEN - News; "MGEN"), manufacturers of nationally branded OTC healthier life products and specialty financial services reports that after 1.5 years of Research and Development, its newest product FABULUST® is ready for market. The FABULUST® product website can be viewed at www.fabulust.net and is linked to the company website www.medgen.com.
ADVERTISEMENT
FABULUST® is an intimate female stimulant aimed at the 46% of women or an estimated 50 million women that reportedly fail to reach satisfaction with their bed partners. The problem and its solution have been the topic of many medical studies emphasizing the importance that sex plays in our daily lives. Finally, Med Gen has introduced a uniquely different product that can be universally accepted, easy to use, enjoy and inexpensive. It is the first roll-on application for a market that exceeds $1.2 billion.
FABULUST® ads will appear shortly in OutlawBiker and Tabu magazines as ticklers, while TV commercials and airtime are procured. The company intends to enter this market with sophisticated TV spots similar to Cialis® and Viagra®.
Along with FABULUST®, the company is now finishing two new commercials for its Painenz® and Snorenz® products. These commercials will air in late October and run through 2008.
In a recent Analyst communication, Mr. Kravitz, Chairman and CEO talked about the raising of substantial capital and the near term emphasis of the company, much of which will be devoted to the marketing of its unique product lines. In this way, he concludes, the company can develop a strong revenue stream and increase shareholder value.
About Med Gen Inc.
Med Gen Inc., in business since 1996, manufactures and markets specialty products using its proprietary delivery system Spray's the Way ("STW"). It is best known for producing the world's first patented liquid spray snoring relief formula, Snorenz®. Since its existence, Med Gen has continued to develop its STW technology, introducing Good Nights Sleep® and the UnDiet® system into its family of brands. Fabulust(TM), the company's newest product, a female sexual stimulant, is scheduled to launch in the late fall of 2007. While STW technology is mainly used, the company also produces other products that deal with common health issues using other delivery systems. Recently, the company formed a joint venture to market TheraPedic CS(TM) an innovative and patented innersole, that amongst other attributes, cools and comforts the feet. The company markets its products to distributors, major chain and drug stores, direct sales via the company web site and direct to consumer television, radio and print advertising. The company also distributes its brands internationally under various private labels or existing names. The Company also offers specialty services to small emerging public companies in similar fields as a way of adding assets to its base business.
Med Gen Inc. is a fully reporting company whose stock trades on the OTCBB under the symbol "MGEN". For information contact Investor Relations 561-750-1100 or www.medgen.com.
This Press Release contains or incorporates by reference "forward looking statements including certain information with respect to plans and strategies of Med Gen Inc. For this purpose, any statements contained herein or incorporated herein by references that are not statements of historical fact may be deemed forward looking statements. Without limiting the foregoing, the words "believes", "suggests", "anticipates", "plans", "expects", and similar expressions are intended to identify forward looking statements. There are a number of events or actual results of Med Gen operations that could differ materially from those indicated by such forward looking statements.
Contact:
Med Gen Inc., Boca Raton
Paul Kravitz, 561-750-1100
www.medgen.com
--------------------------------------------------
Source: Med Gen Inc. |
